HemaSphere (Aug 2023)
P1023: AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM): EFFICACY AND SAFETY ANALYSES FROM THE PHASE 2 PATHFINDER STUDY WITH 2-YEAR FOLLOW-UP
- Jason Gotlib,
- Andreas Reiter,
- Deepti Radia,
- Michael Deininger,
- Tracy George,
- Jens Panse,
- Alessandro Vannucchi,
- Uwe Platzbecker,
- Ivan Alvarez-Twose,
- Andrzej Mital,
- Olivier Hermine,
- Ingunn Dybedal,
- Elizabeth O. Hexner,
- Lambert Span,
- Ruben Mesa,
- Prithviraj Bose,
- Kirsten Pettit,
- Stephen Oh,
- Hui-Min Lin,
- Sasa Dimitrijevic,
- Javier Muñoz-González,
- Daniel J. Deangelo
Affiliations
- Jason Gotlib
- 1 Stanford Cancer Institute/Stanford University School of Medicine, Division of Hematology, Stanford, United States
- Andreas Reiter
- 2 University Hospital Mannheim, Heidelberg University, Department of Hematology and Oncology, Heidelberg, Germany
- Deepti Radia
- 3 Guy’s & St Thomas’s NHS Foundation Trust, London, United Kingdom
- Michael Deininger
- 4 Versiti Blood Research Institute, Milwaukee, United States
- Tracy George
- 5 ARUP Laboratories, University of Utah, Salt Lake City, United States
- Jens Panse
- 6 University Hospital Aachen, Medical Faculty, RWTH Aachen University, Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, Aachen, Germany
- Alessandro Vannucchi
- 7 Azienda Ospedaliera Universitaria Careggi, University of Florence, Center for Research and Innovation of Myeloproliferative Neoplasms – CRIMM, Florence, Italy
- Uwe Platzbecker
- 8 Leipzig University, Leipzig, Germany
- Ivan Alvarez-Twose
- 9 Institute of Mastocytosis Studies of Castilla-La Mancha, Spanish Reference Center of Mastocytosis, Toledo, Spain
- Andrzej Mital
- 10 Medical University of Gdansk, Department of Hematology and Transplantology, Gdansk, Poland
- Olivier Hermine
- 11 Necker–Enfants Malades Hospital, APHP, and Imagine Institute, Department of Hematology, CEREMAST, Paris, France
- Ingunn Dybedal
- 12 Oslo University Hospital, Department of Hematology, Oslo, Norway
- Elizabeth O. Hexner
- 13 Abramson Cancer Center, University of Pennsylvania, Philadelphia, United States
- Lambert Span
- 14 University Medical Center Groningen, Department of Hematology, Groningen, The Netherlands
- Ruben Mesa
- 15 Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, United States
- Prithviraj Bose
- 16 The University of Texas MD Anderson Cancer Center, Houston, United States
- Kirsten Pettit
- 17 University of Michigan, Division of Hematology/Oncology, Ann Arbor, United States
- Stephen Oh
- 18 Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, United States
- Hui-Min Lin
- 19 Blueprint Medicines Corporation, Cambridge, United States
- Sasa Dimitrijevic
- 20 Blueprint Medicines (Switzerland) GmbH, Zug, Switzerland
- Javier Muñoz-González
- 20 Blueprint Medicines (Switzerland) GmbH, Zug, Switzerland
- Daniel J. Deangelo
- 21 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000970992.31848.76
- Journal volume & issue
-
Vol. 7
p. e3184876
Abstract
No abstracts available.